XML 20 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations And Comprehensive Income (Loss) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenues:        
Revenues $ 151,757 $ 60,774 $ 319,748 $ 67,109
Operating expenses:        
Cost of sales 1,551 433 3,355 494
Research and development 35,482 22,463 121,417 96,213
Sales, general and administrative 60,401 43,873 179,952 113,597
Total operating expenses 97,434 66,769 304,724 210,304
Income (loss) from operations 54,323 (5,995) 15,024 (143,195)
Other (expense) income:        
Interest expense (7,672) (7,337) (22,767) (12,104)
Investment income and other, net 4,113 2,207 10,776 5,863
Total other expense, net (3,559) (5,130) (11,991) (6,241)
Net income (loss) $ 50,764 $ (11,125) $ 3,033 $ (149,436)
Net income (loss) per common share:        
Basic $ 0.56 $ (0.13) $ 0.03 $ (1.70)
Diluted $ 0.52 $ (0.13) $ 0.03 $ (1.70)
Shares used in the calculation of net income (loss) per common share:        
Basic 90,555 88,325 90,064 87,894
Diluted 96,798 88,325 95,272 87,894
Other comprehensive income (loss):        
Net income (loss) $ 50,764 $ (11,125) $ 3,033 $ (149,436)
Net unrealized gain (loss) on available-for-sale securities 753 179 (206) (216)
Comprehensive income (loss) 51,517 (10,946) 2,827 (149,652)
Product sales, net        
Revenues:        
Revenues 111,291 45,774 279,282 52,109
Collaboration revenue        
Revenues:        
Revenues $ 40,466 $ 15,000 $ 40,466 $ 15,000